Department of Academic Surgery, University Hospital Southampton, Southampton, UK.
Laparoscopic and Robotic Colorectal Unit, Fundação Champalimaud, Lisbon, Portugal.
Langenbecks Arch Surg. 2019 Aug;404(5):547-555. doi: 10.1007/s00423-019-01806-w. Epub 2019 Aug 3.
Two non-inferiority randomised control trials have questioned the utility of laparoscopic surgery for rectal cancer by failing to prove that pathological markers of high-quality surgery are equivalent to those achieved by open technique. We present short- and long-term post-operative outcomes from the largest single surgeon series of consecutive patients undergoing laparoscopic TME for rectal cancer. We describe the standardised laparoscopic technique developed by the principal surgeon, and the short-term outcomes from three surgeons who were trained in and subsequently adopted the same approach.
Prospectively acquired data from consecutive patients undergoing surgery for rectal cancer by the principal surgeon at the minimally invasive colorectal unit in Portsmouth between 2006 and 2014 were analysed along with data acquired between 2010 and 2017 from surgeons at three further international centres. Endpoints were overall and disease-free survival at 5 years, and early post-operative clinical and pathological outcomes.
Two hundred sixty-three consecutive patients underwent laparoscopic TME surgery by the principal surgeon. At 5 years, overall survival was 82.9% (Dukes' A = 94.4%; B = 81.6%; C = 73.7%); disease-free survival was 84.0% (Dukes' A = 93.3%; B = 86.8%; C = 72.6%). Post-operative length of stay, lymph node harvest, mean operating time, rate of conversion, major morbidity and 30-day mortality were not significantly different between the principal surgeon and those he had trained when subsequently in independent practices.
Laparoscopic TME produces excellent long-term survival outcomes for patients with rectal cancer. A standardised approach has the potential to improve outcomes by setting benchmarks for surgical quality, and providing a step-by-step method for surgical training.
两项非劣效性随机对照试验未能证明腹腔镜手术在高质量手术的病理标志物方面与开放技术相当,从而对直肠癌的腹腔镜手术的实用性提出了质疑。我们呈现了最大的单外科医生系列连续接受腹腔镜 TME 治疗直肠癌患者的短期和长期术后结果。我们描述了由主要外科医生开发的标准化腹腔镜技术,以及三位接受过培训并随后采用相同方法的外科医生的短期结果。
从 2006 年至 2014 年期间,在朴茨茅斯微创结直肠单位由主要外科医生对直肠癌患者进行前瞻性手术获取的数据进行了分析,并结合 2010 年至 2017 年来自另外三个国际中心的外科医生的数据进行了分析。研究终点为 5 年的总生存率和无病生存率,以及术后早期的临床和病理结果。
263 例连续患者接受了主要外科医生的腹腔镜 TME 手术。5 年总生存率为 82.9%(Dukes' A=94.4%;B=81.6%;C=73.7%);无病生存率为 84.0%(Dukes' A=93.3%;B=86.8%;C=72.6%)。术后住院时间、淋巴结采集、平均手术时间、转化率、主要发病率和 30 天死亡率在主要外科医生与他在独立实践中培训的外科医生之间没有显著差异。
腹腔镜 TME 为直肠癌患者带来了极好的长期生存结果。标准化方法有可能通过为手术质量设定基准并为手术培训提供逐步方法来改善结果。